29 research outputs found
Additional file 1 of Pigmented paravenous retinochoroidal atrophy with acute angle-closure glaucoma and posterior subcapsular cataract: a case report
Additional file 1. Patient perspective
Results of ordinal logistic regression on the main travel purpose influence the rental time of UGB and UGA.
Results of ordinal logistic regression on the main travel purpose influence the rental time of UGB and UGA.</p
Auto clustering information of rented car usage.
Auto clustering information of rented car usage.</p
New Blood–Brain Barrier Models Using Primary Parkinson’s Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems
Parkinson’s disease (PD) is
a progressive neurodegenerative
disorder characterized by motor system defects due to the loss of
dopaminergic neurons. A significant contributor to the current limited
therapeutic treatments for PD is the poor penetration of potential
drugs through the blood–brain barrier (BBB). The BBB is a highly
specialized neurovascular system that separates components of the
circulating blood from neurons. There is a great need to develop in
vitro BBB models that retain fundamental characteristics and reliably
predict the permeability of drug candidates. BBB breakdown may initiate
and/or contribute to neuronal dysfunction and loss in diseases such
as PD. However, there is no in vitro BBB model that mimics the pathological
state of PD. To construct in vitro BBB models for drug delivery systems
in the developing central nervous system (CNS), we isolated high purity
endothelial cells from both normal and PD rat brain microvessels.
The primary rat endothelial cell cultures maintained the properties
of their in vivo counterparts. We developed and characterized in vitro
rat endothelial cell and C6 glial cell coculture BBB models. We further
examined the morphological and functional integrity of the barriers.
The in vitro coculture BBB models we established displayed the typical
cytoarchitecture and cellular markers by immunofluorescence staining
and electron microscopy, high transendothelial electrical resistance
(>300 Ω cm2), and a low permeability value (<3
× 10–6 cm/s). Our new models can be used to
study BBB dysfunctions in relation to the pathogenesis and progression
of PD, as well as a screening tool to test candidate drugs for PD
treatment
